Tag: CORO
Spike RBD IgG Antibodies Persist After SARS-CoV-2 Infection
Antibody levels higher for children versus adults across all follow-up time points up to 10 months after infection
Breakthrough Infections in Lupus Patients Down With COVID Booster
Sixty-four percent of those with breakthrough COVID-19 had received booster compared with 82 percent of those without breakthrough infection
Biden Administration May Back Second Booster Shots for All Adults
Expanding eligibility requirements for a fourth dose of the vaccine would require regulatory approval
Infant Hospitalization for COVID-19 Reduced With Maternal Vaccination
Effectiveness of maternal vaccination against COVID-19 hospitalization in infants 80 percent during delta, 38 percent during omicron
New Omicron Subvariant Spreading in India, United States
New mutation -- BA.2.75 -- has been detected in 10 other countries, including Australia, Germany, the United Kingdom, and Canada
Adverse Reactions to BNT162b2 Mild, Moderate for 5- to 11-Year-Olds
Based on data from three U.S. safety monitoring systems, adverse events were mild-to-moderate, and myocarditis occurred rarely
COVID-19 Among Top 5 Causes of Death in the U.S.
As pandemic wears on, ranking of COVID-19 as a leading cause of death has increased among younger age groups
Immunocompromised Hospitalized With COVID-19 Have Poor Outcomes
Immunocompromised patients have increased odds of ICU admission, in-hospital death, regardless of vaccination status
One in 13 U.S. Adults Report Long COVID Symptoms
Rates higher among younger adults and women, with some geographic variation
FDA Allows Pharmacists to Prescribe COVID-19 Drug Paxlovid
However, patients who test positive for COVID-19 should still consider reaching out to their regular health care provider for Paxlovid first